Correlation Between Surrozen and Fate Therapeutics

Can any of the company-specific risk be diversified away by investing in both Surrozen and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Surrozen and Fate Therapeutics, you can compare the effects of market volatilities on Surrozen and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Fate Therapeutics.

Diversification Opportunities for Surrozen and Fate Therapeutics

0.14

Correlation Coefficient

Surrozen  Fate Therapeutics

Average diversification

The 3 months correlation between Surrozen and Fate is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Surrozen i.e., Surrozen and Fate Therapeutics go up and down completely randomly.

Pair Corralation between Surrozen and Fate Therapeutics

Given the investment horizon of 90 days Surrozen is expected to generate 0.79 times more return on investment than Fate Therapeutics. However, Surrozen is 1.27 times less risky than Fate Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.17 per unit of risk. If you would invest  909.00  in Surrozen on September 24, 2024 and sell it today you would earn a total of  314.00  from holding Surrozen or generate 34.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Surrozen  vs.  Fate Therapeutics

Surrozen

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Surrozen displayed solid returns over the last few months and may actually be approaching a breakup point.

Fate Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Surrozen and Fate Therapeutics

The main advantage of trading using opposite Surrozen and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.

The idea behind Surrozen and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.